(A) Fitting a beta distribution to permuted screens. The transformed cosine similarity density curves of the permuted data are colored in grey. The fitted beta distribution is plotted as a dashed green curve. (B) Fitting a beta-mixture distribution to screening data. The transformed cosine similarities of the real screening data is shown in the grey histogram. Fitted beta distributions representing the

,

and

mixture component are plotted as red, blue and green dashed curves, respectively. The black dashed curve denotes the fitted mixed distribution. (C) Predicted significant modules. The significant modules predicted by
PAN are presented in a nested structure. Each module is illustrated by a rounded rectangle including sub-modules and/or individual genes. The
p-value (on the top of each module) computed by
pvclust indicates the stability of genes being clustered together.
PRCKA (the gene colored in purple) is known to be a kinase target for human sarcomas, and an inhibitor PKC412 targeting
PRCKA has already been tested in the clinic.
STK10 and
TNK2 (colored in red) in the upper left module have been identified as potential therapeutic targets. Another eight genes (colored in yellow) in the upper left and right modules were also highly associated with apoptosis of Ewing's sarcoma. (D) Significantly overrepresented KEGG pathways. Hypergeometric tests were performed to evaluate overrepresentation of genes included in the upper right module in human KEGG pathways. Top significant pathways (
p-value

) are ranked by
p-value increasingly, and their corresponding ratios of the number of observed hits to expected hits are illustrated by a bar plot. Most of these significant pathways are related to cell proliferation (colored in red), smooth muscle contraction (colored in green), immune system response (colored in orange) and cancer (colored in blue).